IRIX

IRIDEX Corporation Press Releases

$11.44
*  
0.03
0.26%
Get IRIX Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading IRIX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

IRIDEX Announces First Quarter 2016 Conference Call and Release Date
4/28/2016 4:05:00 PM - PR Newswire
▲0.26 % Price Change since this news event. The Volume Ratio is 1.37.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


IRIDEX Gains Patent Approvals Covering TxCell™-Guided MicroPulse® Laser Therapy; Predictably Enables Faster, Durable Treatments for Glaucoma and Retinal Diseases
3/22/2016 4:05:00 PM - PR Newswire
▲10.75 % Price Change since this news event. The Volume Ratio is 0.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


IRIDEX Reports 2015 Fourth Quarter, Full Year Results
3/3/2016 4:05:00 PM - PR Newswire
▲13.04 % Price Change since this news event. The Volume Ratio is 2.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


IRIDEX Announces Fourth Quarter and Full Year 2015 Conference Call and Release Date
2/25/2016 4:05:00 PM - PR Newswire
▲17.94 % Price Change since this news event. The Volume Ratio is 2.87.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


IRIDEX Receives CE Mark for Cyclo G6™ Laser System for the Treatment of Multiple Stages of Glaucoma
2/16/2016 6:30:00 AM - PR Newswire
▲23.81 % Price Change since this news event. The Volume Ratio is 0.53.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day